Rein Therapeutics
RNTX
$2.29
Share price
0.00%
Change (1 day)
-72.66%
Change (1 year)
Categories
EPS for Rein Therapeutics (RNTX)
EPS in 2024 (TTM): -$2.66
According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.66. In 2023 the company made an earnings per share (EPS) of -$4.60 an increase over its 2022 EPS that were of -$8.10.
EPS history for Rein Therapeutics from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$2.66 | -42.14% |
| 2023 | -$4.60 | -43.19% |
| 2022 | -$8.10 | 2.21% |
| 2021 | -$7.93 | -51.72% |
| 2020 | -$16.42 | -49.17% |
| 2019 | -$32.30 | -43.93% |
| 2018 | -$57.59 | -29.61% |
| 2017 | -$81.81 | 82.33% |
| 2016 | -$44.87 | 40.54% |
| 2015 | -$31.93 |